Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

58 - “Revolutionizing Drug Discovery and Development with AI-Powered in silico Solutions”

BACK

58 - “Revolutionizing Drug Discovery and Development with AI-Powered in silico Solutions”

Abstract:

Join an insightful webinar led by InSilicoTrials CEO Luca Emili to explore the cutting-edge advancements of in silico methodologies. Discover how AI, paired with computational modeling and simulation (M&S), is revolutionizing the drug development process by predicting outcomes with remarkable precision and speed.

This webinar will demonstrate how InSilicoTrial's technology delivers a more efficient and cost-effective drug development pathway, significantly reducing the need for early-stage human trials and enhancing decision-making. This is essential for researchers, scientists, and industry professionals seeking to leverage in silico tools for groundbreaking discoveries and stay ahead of emerging trends.

IMAGE GALLERY:

Luca Emili

Luca Emili

Co-Chair of the Good Simulation Practice (GSP) Task Force

CEO, InSilicoTrials Technologies

READ BIO
Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2026 Avicenna Alliance | powered by We Berry